Literature DB >> 24269703

The imbalanced profile and clinical significance of T helper associated cytokines in bone marrow microenvironment of the patients with acute myeloid leukemia.

Yuan-xin Sun1, Hai-li Kong2, Chuan-fang Liu1, Shuang Yu1, Tian Tian1, Dao-xin Ma3, Chun-yan Ji1.   

Abstract

BACKGROUND: Immunological disorder has shown to be related to the pathogenesis of acute myeloid leukemia (AML). The microenvironment of AML is immunosuppressive, favoring the survival of malignant hematopoietic cells. However, the systematic research on AML abnormal immune microenvironment, especially the T helper (Th) cells imbalance, remains unsettled. DESIGN AND METHODS: The levels of cytokines in bone marrow plasma including Th1-associated cytokine (IFN-γ), Th2-associated cytokine (IL-4), Th17-associated cytokines (IL-17, IL-6, TGF-β, and IL-21), regulatory T cell (Treg)-associated cytokines (IL-35 and IL-10) and Th22-associated cytokine (IL-22) were examined by enzyme-linked immunosorbent assay (ELISA) in AML patients and controls. The relative expression levels of IL-4, IL-10, and IL-21 mRNA were analyzed by real time polymerase chain reaction (PCR).
RESULTS: Significant differences on cytokine levels tested were observed among the AML newly-diagnosed (ND) patients, AML patients in complete remission (CR) and controls except IL-21 and IL-35. In AML-ND group IFN-γ level was positively correlated with IL-21 or IL-22 level. Additionally, significant associations were observed between IL-17, IL-21 and some clinical characteristics.
CONCLUSION: Our results showed that many cytokines were abnormal in AML bone marrow microenvironment. The dysregulation of Th subsets cytokines is thought to contribute to the pathogenesis of AML.
Copyright © 2013 American Society for Histocompatibility and Immunogenetics. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  AML; AMML; AMoL; APL; BM; CR; Ca; EL; ELISA; Hb; LDH; LYM; ND; NEU; PB; PLT; RT-PCR; T helper type 1; Th1; Treg; WBC; acute monocytic leukemia; acute myeloid leukemia; acute myelomonocytic leukemia; acute promyelocytic leukemia; bone marrow; calcium; complete remission; enzyme-linked immunosorbent assay; erythroleukemia; hemoglobin; lactate dehydrogenase; lymphocyte; neutrophil; newly diagnosed; peripheral blood; platelet; real time polymerase chain reaction; regulatory T cell; white blood cell count

Mesh:

Substances:

Year:  2013        PMID: 24269703     DOI: 10.1016/j.humimm.2013.11.014

Source DB:  PubMed          Journal:  Hum Immunol        ISSN: 0198-8859            Impact factor:   2.850


  14 in total

Review 1.  Alterations of T-cell-mediated immunity in acute myeloid leukemia.

Authors:  Zhuoyan Li; Mary Philip; P Brent Ferrell
Journal:  Oncogene       Date:  2020-03-03       Impact factor: 9.867

Review 2.  Immunomodulatory Drugs: Immune Checkpoint Agents in Acute Leukemia.

Authors:  Hanna A Knaus; Christopher G Kanakry; Leo Luznik; Ivana Gojo
Journal:  Curr Drug Targets       Date:  2017       Impact factor: 3.465

3.  Elevated plasma phage load as a marker for intestinal permeability in leukemic patients.

Authors:  Xue-Rui Yin; Ping Liu; Xi Xu; Ying Xia; Kai-Zhao Huang; Qiong-Dan Wang; Mei-Mei Lai; Qi-Gui Yu; Xiao-Qun Zheng
Journal:  Med Microbiol Immunol       Date:  2020-09-29       Impact factor: 3.402

Review 4.  Common gamma chain cytokines in combinatorial immune strategies against cancer.

Authors:  Stephanie R Pulliam; Roman V Uzhachenko; Samuel E Adunyah; Anil Shanker
Journal:  Immunol Lett       Date:  2015-11-17       Impact factor: 3.685

5.  Higher PD-1 expression concurrent with exhausted CD8+ T cells in patients with de novo acute myeloid leukemia.

Authors:  Jiaxiong Tan; Shaohua Chen; Yuhong Lu; Danlin Yao; Ling Xu; Yikai Zhang; Lijian Yang; Jie Chen; Jing Lai; Zhi Yu; Kanger Zhu; Yangqiu Li
Journal:  Chin J Cancer Res       Date:  2017-10       Impact factor: 5.087

6.  Neuropathy correlated with imbalanced Foxp3/IL-17 in bone marrow microenvironment of patients with acute myeloid leukemia.

Authors:  Chen Chen; Yan Liu; Mingqiang Hua; Xiaomei Li; Chunyan Ji; Daoxin Ma
Journal:  Oncotarget       Date:  2016-04-26

Review 7.  IL-35: a potential therapeutic target for controlling hepatitis B virus infection.

Authors:  Xiao Gang Xiang; Qing Xie
Journal:  J Dig Dis       Date:  2015-01       Impact factor: 2.325

8.  Progranulin depletion inhibits proliferation via the transforming growth factor beta/SMAD family member 2 signaling axis in Kasumi-1 cells.

Authors:  Kuniaki Yabe; Yasuko Yamamoto; Masao Takemura; Takeshi Hara; Hisashi Tsurumi; Ginette Serrero; Toshitaka Nabeshima; Kuniaki Saito
Journal:  Heliyon       Date:  2021-01-08

Review 9.  The Newly Identified T Helper 22 Cells Lodge in Leukemia.

Authors:  Gholamreza Azizi; Mohsen Rastegar Pouyani; Shadi Sadat Navabi; Reza Yazdani; Fatemeh Kiaee; Abbas Mirshafiey
Journal:  Int J Hematol Oncol Stem Cell Res       Date:  2015-07-01

10.  Levels and Clinical Significance of Regulatory B Cells and T Cells in Acute Myeloid Leukemia.

Authors:  Qiaofeng Dong; Guosheng Li; Claudio Fozza; Shuli Wang; Shuhuan Yang; Yuqi Sang; Xinguang Liu; Chunyan Chen
Journal:  Biomed Res Int       Date:  2020-10-06       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.